drugset / Trial / NCT06236815

High Confusion: Cannabis & Driving

NCT06236815

Phase 0 Completed 5 enrolled University of Wisconsin, Madison
RandomizedCrossoverDouble-blindDiagnostic

Summary

This study is being done to assess the feasibility of administrating Δ9-THC and Δ8-THC isolates and simultaneously adopting several data harmonization measures to generate uniquely translatable data. This project aims to (1) evaluate the feasibility and acceptability of administering ∆9-THC and Δ8-THC isolates using standardized cannabis dosing units to quantify ∆9-THC and Δ8-THC pharmacokinetics; and (2) evaluate the feasibility and acceptability of adopting standardized impairment detection methods and driving performance definitions and measures on quantifying ∆9-THC and Δ8-THC driving impairment compared to a placebo.

Timeline

Start
2025-01-25
Primary completion
2025-09-16
Completion
2025-09-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Delta-8-Tetrahydrocannabinol Other / unclassified Other
Subject Dronabinol Other / unclassified Other